Engaging community pharmacists in the primary prevention of cardiovascular disease: Protocol for the pharmacist assessment of adherence, risk and treatment in cardiovascular disease (PAART CVD) pilot study

BMC Health Services Research

Volumn 10, Issue , 2010, Pages

  Mc Namara, Kevin P ^a,b   George, Johnson ^a   O'Reilly, Sharleen L ^c   Jackson, Shane L ^d   Peterson, Gregory M ^d   Howarth, Helen ^d   Bailey, Michael J ^a   Duncan, Gregory ^a,e   Trinder, Peta ^a   Morabito, Elizabeth ^a   Finch, Jill ^d   Bunker, Stephen ^b   Janus, Edward ^b,f   Emery, Jon ^g   Dunbar, James A ^b  

^a MONASH UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

AGED; ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; FEMALE; HEALTH CARE QUALITY; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MORTALITY; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PILOT STUDY; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK ASSESSMENT; RURAL POPULATION; STATISTICS; TREATMENT OUTCOME; URBAN POPULATION;

AGED; AUSTRALIA; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; COMMUNITY PHARMACY SERVICES; FEMALE; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHARMACISTS; PILOT PROJECTS; PRIMARY PREVENTION; PROGRAM EVALUATION; RISK ASSESSMENT; RURAL POPULATION; TREATMENT OUTCOME; URBAN POPULATION;

EID: 79952117012     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-264     Document Type: Article

References (39)

1. Global Burden of Disease and Risk Factors. Lopez AD, Begg S, Bos E, Demographic and Epidemiological Characteristics of Major Regions, 1990-2001 Oxford: Oxford University Press/World Bank, Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, 2006 http://files.dcp2.org/pdf/GBD/GBD.pdf Downloaded 28 April 2010
2. The economics of primary prevention of cardiovascular disease-a systematic review of economic evaluations. Schwappach D, Boluarte T, Suhrcke M, Cost Eff Resour Alloc 2007 5 1 5 10.1186/1478-7547-5-5 17501999 (Pubitemid 46851049)
3. Australia's Health 2008. Australian Institute of Health and Welfare, Canberra 2008
4. Sensitivity of Patient Outcomes to Pharmacist Interventions. Part II: Systematic Review and Meta-Analysis in Hypertension Management. Machado M, Bajcar J, Guzzo GC, Einarson TR, Ann Pharmacother 2007 41 11 1770 81 10.1345/aph.1K311 17925496 (Pubitemid 350044338)
5. Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk. Tsuyuki R, Johnson J, Teo K, Ackman M, Biggs R, Cave A, Chang WC, Dzavik V, Farris KB, Galvin D, Semchuk W, Simpson SH, Taylor JG, Ann Pharmacother 1999 33 9 910 19 10.1345/aph.18380 10492489 (Pubitemid 29420983)
6. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. Blenkinsopp A, Anderson C, Armstrong M, J Public Health 2003 25 2 144 53 10.1093/pubmed/fdg030 (Pubitemid 36758777)
7. Community pharmacy personnel interventions for smoking cessation. Sinclair HK, Bond CM, Stead LF, Cochrane Database of Systematic Reviews 2004 1 D003698
8. Position Statement on Lipid Management-2005. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand, Heart Lung Circ 2005 14 275 91 10.1016/j.hlc.2005.10.010 16361000
9. Guidelines for the assessment of absolute cardiovascular disease risk. National Vascular Disease Prevention Alliance, National Heart Foundation of Australia 2009 http://www.heartfoundation.org.au/Professional-Information/ General-Practice/Pages/AbsoluteRisk.aspx Downloaded 28 April 2010
10. Guide to management of hypertension. National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee), 2008
11. The Assessment and Management of Cardiovascular Risk. New Zealand Guideline Group, 2003 http://www.nhf.org.nz/files/CVD-Risk-Full.pdf Downloaded 28 April 2010
12. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Eur Heart J 2007 28 19 2375 414 10.1093/eurheartj/ehm316 17726041 (Pubitemid 47542237)
13. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. World Health Organisation, Geneva 2007
14. Effect of a Pharmaceutical Care Program on Vascular Risk Factors in Type 2 Diabetes. Clifford RM, Davis WA, Batty KT, Davis TME, Diabetes Care 2005 28 4 771 76 10.2337/diacare.28.4.771 15793171 (Pubitemid 40434471)
15. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J, Diabet Med 2007 24 6 677 83 10.1111/j.1464-5491.2007.02143.x 17523968 (Pubitemid 46808869)
16. A Collaborative, Interdisciplinary Evidence Based Approach to Reducing Coronary Heart Disease in Rural Areas. Emerson L, Krass I, Canberra: Pharmacy Guild of Australia 2006
17. Cardiovascular disease risk profiles. Anderson KM, Odell PM, Wilson PW, Kannel WB, Am Heart J 1991 121 1 Pt 2 293 8 10.1016/0002-8703(91)90861-B 1985385
18. Clinical performance of the Cardiocheck P.A and the Cholestech LDX System compared to a Clinical Diagnostic Laboratory Reference Method for the Determination of Lipid Profiles. Cholestech Corporation, 2002 http://www.cholestech.com/docs/ldx-accuracy/tbCardioChek.pdf Downloaded 28 April 2010
19. Accuracy and precision of the Cholestech LDX system in monitoring blood lipid levels. Santee J, Am J Health Syst Pharm 2002 59 1774 1779 12298117 (Pubitemid 35033917)
20. European Health Risk Monitoring Project. Recommendation for indicators, international collaboration, protocol and manual of operations for chronic disease risk factor surveys. Tolonen H, Kuulasmaa K, Laatikainen T, Wolf H, 2002 12364723
21. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators, J Clin Epidemiol 1988 41 2 105 14 10.1016/0895-4356(88)90084-4 3335877 (Pubitemid 18069569)
22. Chronic Disease Risk Factors in Rural Australia: Results From the Greater Green Triangle Risk Factor Surveys. Laatikainen T, Janus E, Kilkkinen A, Heistaro S, Tideman P, Baird A, Tirimacco R, Whiting M, Franklin L, Chapman A, Kao-Philpot A, Dunbar JA, Asia Pac J Public Health 2009 21 1 51 62 19124336
23. Development and validation of the Beliefs and Behaviour Questionnaire (BBQ). George J, Mackinnon A, Kong DCM, Stewart K, Patient Education and Counseling 2006 64 1-3 50 60 10.1016/j.pec.2005.11.010 16843634 (Pubitemid 44772940)
24. Concurrent and predictive validity of a self-reported measure of medication adherence. Morisky DE, Green LW, Levine DM, Med Care 1986 24 1 67 74 10.1097/00005650-198601000-00007 3945130 (Pubitemid 16125389)
25. Lifescripts Practice Manual: Supporting Lifestyle Risk Factor Management in General Practice. Kinect Australia for the Lifescripts consortium, Canberra: Commonwealth of Australia 2005
26. Dietary Guidelines for Australian Adults. National Health and Medical Research Council, Canberra 2003
27. National Nutrition Survey: Nutrient Intakes and Physical Measurements Australia 1995. McLennan W, Podger A, Canberra: Australian Bureau of Statistics 1998
28. The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G, Aust N Z J Public Health 2000 24 6 576 83 10.1111/j.1467-842X.2000.tb00520.x 11215004 (Pubitemid 32094232)
29. The AUDIT Alcohol Consumption Questions (AUDIT-C): An Effective Brief Screening Test for Problem Drinking. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA, for the Ambulatory Care Quality Improvement Project, Arch Intern Med 1998 158 16 1789 95 10.1001/archinte.158.16.1789 9738608 (Pubitemid 28421422)
30. The CES-D scale: A self-report depression scale for research in the general population. Radloff LS, Appl Psychol Meas 1977 385 401 10.1177/014662167700100306
31. User's manual for the SF-12v2 Health Survey. Ware JE, Kosinski M, Turner-Bowker DM, Gandeck B, Boston: Quality Metrics 2007
32. Modeling Health Behavior Change: How to Predict and Modify the Adoption and Maintenance of Health Behaviors. Schwarzer R, Appl Psychol 2008 57 1 1 29 10.1111/j.1464-0597.2007.00325.x
33. Dietary Quality Is Associated with Diabetes and Cardio-Metabolic Risk Factors. McNaughton SA, Dunstan DW, Ball K, Shaw J, Crawford D, J Nutr 2009 139 4 734 42 10.3945/jn.108.096784 19211825
34. Vascular Risk Checks in the UK: strategic challenges for implementation. Patel KC, Minhas R, Gill P, Khunti K, Heart 2009 (online), hrt.2008.165035 19332419
35. Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies. Horgan JMP, Blenkinsopp A, McManus RJ, J Public Health 2009 (online), fdp092
36. Rural community pharmacy: a feasible site for a health promotion and screening service for cardiovascular risk factors. Hourihan F, Krass I, Chen T, Hourihan F, Krass I, Chen T, Aust J Rural Health 2003 11 1 28 35 10.1046/j.1440-1584.2003.00468.x 12603444 (Pubitemid 37038451)
37. Health promotion and screening for cardiovascular risk factors in NSW: a community pharmacy model. Krass I, Hourihan F, T C, Health Promot J Austr 2003 14 2 101 07
38. Type 2 Diabetes Prevention in the 'Real World'. Absetz P, Valve R, Oldenburg B, Heinonen H, Nissinen A, Fogelholm M, Ilvesmaki V, Talja M, Uutela A, Diabetes Care 2007 30 10 2465 70 10.2337/dc07-0171 17586741 (Pubitemid 47547773)
39. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project. Laatikainen T, Dunbar JA, Chapman A, Kilkkinen A, Vartiainen E, Heistaro S, et al. BMC Public Health 2007 7 249 10.1186/1471-2458-7-249 17877832 (Pubitemid 47622275)